Bloodless management of benign prostatic hyperplasia: medical and minimally invasive treatment options
The Aging Male, 08/16/2011Liatsikos E et al.
Benign prostatic hyperplasia (BPH) is a medical condition affecting a wide range of the aging male population resulting in various degrees of lower urinary tract symptoms (LUTS). A variety of medical therapies and minimally invasive BPH treatment modalities are available. Medical therapy includes αα1 blockers, 5 αα reductase inhibitors and combination therapy. In this article, current treatment options for BPH are reviewed with respect to their indications, long-term safety and efficacy in relieving BPH related LUTS. The selection of the type of BPH treatment should be based on the physician's experience, patient's co-morbidities as well as the prostate size and clinical disease progression.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.